Levofloxacin Prophylaxis in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation Recipients Does not Prevent Infective Complications and Infections-related Deaths
LVX prophylaxis in the setting of allo-HCT does not prevent infective complications and increases the prevalence of antibiotic-resistant strains.
Authors
- Francesca Gottardi (ORCID: https://orcid.org/0000-0002-2325-3671)
- Francesco Baccelli (ORCID: https://orcid.org/0000-0001-8313-7288)
- Francesco Venturelli (ORCID: https://orcid.org/0000-0002-7133-3713)
- Davide Leardini (ORCID: https://orcid.org/0000-0002-4673-5876)
- Tamara Belotti
- Marco Fabbrini (ORCID: https://orcid.org/0000-0003-1431-0643)
- Riccardo Masetti (ORCID: https://orcid.org/0000-0002-1264-057X)
- Silvia Turroni (ORCID: https://orcid.org/0000-0003-2345-9482)
- Edoardo Muratore (ORCID: https://orcid.org/0000-0001-6954-3140)
- Arcangelo Prete (ORCID: https://orcid.org/0000-0002-6823-3797)
- Patrizia Brigidi (ORCID: https://orcid.org/0000-0001-8375-6150)
- Giacomo Gambuti (ORCID: https://orcid.org/0009-0009-0079-3438)
Institutions
- Azienda USL di Bologna (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-11-28
- DOI
- https://doi.org/10.1093/ofid/ofae707
- Citations
- 6
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 1.70
Funders
- Ministero della Salute